Evidence map›Paper›PMID 37040858›Full record

ArticleNanoImpact2023

TRAAC framework to improve regulatory acceptance and wider usability of tools and methods for safe innovation and sustainability of manufactured nanomaterials.

Neeraj Shandilya, Marie-Sophie Barreau, Blanca Suarez-Merino, Andrea Porcari, Daniela Pimponi, Keld Alstrup Jensen, Wouter Fransman, Remy Franken

Abstract read
In one paragraph

Article in NanoImpact, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Neeraj ShandilyaTNO, Princetonlaan 6, 3584 CB Utrecht, Netherlands. Electronic address: neeraj.shandilya@tno.nl.
Marie-Sophie BarreauTNO, Princetonlaan 6, 3584 CB Utrecht, Netherlands.
Blanca Suarez-MerinoTEMAS Solutions GmbH, Lätteweg 5, 5212 Hausen, Switzerland.
Andrea PorcariItalian Association for Industrial Research, Airi, Viale Gorizia 25/C, 00198 Rome, Italy.
Daniela PimponiItalian Association for Industrial Research, Airi, Viale Gorizia 25/C, 00198 Rome, Italy.
Keld Alstrup JensenNational Research Centre for the Working Environment, 105 Lersø Parkallé, DK-2100 Copenhagen, Denmark.
Wouter FransmanTNO, Princetonlaan 6, 3584 CB Utrecht, Netherlands.
Remy FrankenTNO, Princetonlaan 6, 3584 CB Utrecht, Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There has been an increasing use of advanced materials, particularly manufactured nanomaterials, in industrial applications and consumer products in the last two decades. It has instigated concerns about the sustainability, in particular, risks and uncertainties regarding the interactions of the manufactured nanomaterials with humans and the environment. Consequently, significant resources in Europe and beyond have been invested into the development of tools and methods to support risk mitigation and risk management, and thus facilitate the research and innovation process of manufactured nanomaterials. The level of risk analysis is increasing, including assessment of socio-economic impacts, and sustainability aspects, moving from a conventional risk-based approach to a wider safety-and-sustainability-by-design perspective. Despite these efforts on tools and methods development, the level of awareness and use of most of such tools and methods by stakeholders is still limited. Issues of regulatory compliance and acceptance, reliability and trust, user-friendliness and compatibility with the users' needs are some of the factors which have been traditionally known to hinder their widespread use. Therefore, a framework is presented to quantify the readiness of different tools and methods towards their wider regulatory acceptance and downstream use by different stakeholders. The framework diagnoses barriers which hinder regulatory acceptance and wider usability of a tool/method based on their Transparency, Reliability, Accessibility, Applicability and Completeness (TRAAC framework). Each TRAAC pillar consists of criteria which help in evaluating the overall quality of the tools and methods for their (i) compatibility with regulatory frameworks and (ii) usefulness and usability for end-users, through a calculated TRAAC score based on the assessment. Fourteen tools and methods were assessed using the TRAAC framework as proof-of-concept and for user variability testing. The results provide insights into any gaps, opportunities, and challenges in the context of each of the 5 pillars of the TRAAC framework. The framework could be, in principle, adapted and extended to the evaluation of other type of tools & methods, even beyond the case of nanomaterials.

Indexed as

NanostructuresEuropeHumansReproducibility of ResultsRisk AssessmentRisk ManagementNanomaterialRegulatory acceptanceRiskSafe innovationSustainability

Identifiers

PMID37040858
PMCPMC10242441

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.